Lophius Biosciences

Lophius Biosciences is a young biotechnology company developing innovative products for the diagnosis of acute infectious and autoimmune diseases.

The company is also offering custom-made services in the area of cell based bioactivity and quality tests for pharmaceutical agents.

The core competencies of Lophius Biosciences are in the area of Immunology and T-cell diagnostics.

Closing of a 2nd financing round and appointment of a new CEO

Monday, 17.05.2010

LOPHIUS closed 2nd financing round and appoints Dr. Michael Lutz as new CEO

Research grant from the Bavarian Ministery of Economics

Tuesday, 23.03.2010

For the development of its tuberculosis diagnostic kit Lophius has received a research grant of approximately 250,000 EUR from the Bavarian Ministery of Economics

U.S. patent granted

Tuesday, 02.03.2010

Lophius announces U.S. patent granted.